{
    "nctId": "NCT05206396",
    "briefTitle": "TIL Relation to pCR After Neoadjuvant Therapy in Breast Cancer Patients",
    "officialTitle": "Do Tumor-Infiltrating Lymphocytes Predict Complete Pathologic Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients?",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 270,
    "primaryOutcomeMeasure": "Assessment of TIL relation to pathologic complete response",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients aged 18 years old or more\n* Histologically proven invasive breast cancer\n* All patients diagnosed with breast cancer except T1N0 and Metastatic breast cancer\n* Patients who completed their systemic neoadjuvant therapy\n\nExclusion Criteria:\n\n* Second malignancy\n* Patients who started but didn't complete neoadjuvant systemic therapy\n* Patients who didn't undergo surgery after neoadjuvant systemic therapy\n* Pregnant patients",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}